XPeng Inc. · XPEV · FY2026 Q1 · Calendar Q2 2026
XPeng raises Q2 delivery outlook as physical AI strategy expands
The quarter supports a constructive growth case: delivery momentum, raised Q2 guidance, international expansion, and new AI-led businesses provide evidence of demand and growth. The case remains dependent on execution, stable margins, and regulatory progress.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about XPEV FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Q2 delivery guidance was raised to 100,000–106,000 vehicles, while management emphasized a broader physical-AI strategy. International sales now exceed 20% of revenue, and R&D spending is focused on AI chips, autonomous driving, and robotics.
Guidance delta
Management raised Q2 delivery guidance to 100,000–106,000 vehicles and expects revenue to grow 50–60% sequentially.
Key takeaways
- Q1 deliveries were 62,680 vehicles despite a weak Chinese NEV market.
- Management raised Q2 delivery guidance and highlighted the GX SUV and Turing AI SoC rollout.
- International sales exceed 20% of revenue, while robotics and robotaxi plans add longer-term optionality.
Management priorities
- Scale the GX SUV and four new global models in H2 2026.
- Expand international sales and localized production in Indonesia, Malaysia, and Austria.
- Advance the Turing AI SoC, autonomous-driving systems, robotaxi platform, and humanoid robot.
Follow XPEV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Underweight | Underweight | Maintain | Aug 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 25, 2026 |
| Macquarie | Outperform | Neutral | Upgrade | May 29, 2026 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Jan 6, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Jan 6, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 20, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 19, 2025 |
| UBS | Neutral | Sell | Upgrade | Feb 24, 2025 |
| China Renaissance | Buy | Hold | Upgrade | Nov 22, 2024 |
| Bernstein | Market Perform | Market Perform | Maintain | Nov 20, 2024 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 11, 2024 |
| CLSA | Buy | Outperform | Maintain | Aug 8, 2023 |
| HSBC | Buy | Hold | Upgrade | Aug 7, 2023 |
| Jefferies | Buy | Hold | Upgrade | Jul 28, 2023 |
| BOCOM International | Sell | Neutral | Downgrade | Jul 7, 2023 |
| Daiwa Capital | Sell | Buy | Downgrade | Dec 14, 2022 |
| Nomura Instinet | Neutral | Buy | Downgrade | Jul 1, 2022 |
Named analyst price targets
Upside is calculated against the persisted previous close $10.29. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Paul Gong | $12 | $10.93 | +16.6% | Sep 9, 2026 |
| Barclays | Jiong Shao | $14 | $11.15 | +36.1% | Aug 25, 2026 |
| Barclays | Analyst unavailable | $15 | $13.78 | +45.8% | Jul 16, 2026 |
| Jefferies | Alexious Lee | $25.2 | $16.44 | +144.9% | May 29, 2026 |
| Macquarie | Eugene Hsiao | $19 | $16.44 | +84.6% | May 28, 2026 |
| Barclays | Analyst unavailable | $17 | $17.84 | +65.2% | Feb 18, 2026 |
| Macquarie | Eugene Hsiao | $26 | $20.9 | +152.7% | Jan 15, 2026 |
| Loop Capital Markets | Roman Lukianchikov | $25 | $20.14 | +143.0% | Jan 6, 2026 |
| Morgan Stanley | Tim Hsiao | $34 | $26.04 | +230.4% | Nov 11, 2025 |
| Goldman Sachs | Tina Hou | $24 | $18.57 | +133.2% | Jun 17, 2025 |
| Morgan Stanley | Tim Hsaio | $28 | $19.23 | +172.1% | Jun 12, 2025 |
| Bernstein | Eunice Lee | $19 | $20.5 | +84.6% | May 22, 2025 |
| Macquarie | Eugene Hsiao | $24 | $22.25 | +133.2% | May 21, 2025 |
| Bernstein | Analyst unavailable | $18 | $23.8 | +74.9% | Mar 19, 2025 |
| CMB International Securities | Ji Shi | $16 | $12.64 | +55.5% | Nov 20, 2024 |
| Morgan Stanley | Tim Hsiao | $17 | $12.88 | +65.2% | Nov 6, 2024 |
| Citigroup | Jeff Chung | $14.6 | $12.72 | +41.9% | Sep 30, 2024 |
| Citigroup | Jeff Chung | $10.3 | $10.7 | +0.1% | Sep 24, 2024 |
| Macquarie | Eugene Hsiao | $10 | $8.41 | -2.8% | Sep 3, 2024 |
| Citigroup | Jeff Chung | $7.6 | $6.77 | -26.1% | Aug 21, 2024 |
| Barclays | Jiong Shao | $7 | $6.77 | -32.0% | Aug 21, 2024 |
| Daiwa | Kelvin Lau | $11 | $8.1 | +6.9% | May 23, 2024 |
| Bernstein | Eunice Lee | $12 | $8.77 | +16.6% | May 22, 2024 |
| Barclays | Jiong Shao | $8 | $8.77 | -22.3% | May 22, 2024 |
| CFRA | Aaron Ho | $8 | $7.76 | -22.3% | Apr 1, 2024 |
| HSBC | Yuqian Ding | $18.7 | $8.52 | +81.7% | Mar 22, 2024 |
| Morgan Stanley | Tim Hsiao | $18 | $9.89 | +74.9% | Mar 19, 2024 |
| Morgan Stanley | Tim Hsiao | $18.7 | $21.89 | +81.7% | Jul 28, 2023 |
| J.P. Morgan | Analyst unavailable | $9 | $10.09 | -12.5% | Jan 11, 2023 |
| Daiwa | Analyst unavailable | $8 | $10.25 | -22.3% | Dec 14, 2022 |
| HSBC | Analyst unavailable | $15 | $10.47 | +45.8% | Dec 13, 2022 |
| Jefferies | Analyst unavailable | $4.2 | $7.07 | -59.2% | Nov 28, 2022 |
| UBS | Analyst unavailable | $13 | $7.76 | +26.3% | Nov 17, 2022 |
| Citigroup | Analyst unavailable | $27.87 | $18.73 | +170.8% | Aug 24, 2022 |
| Barclays | Jiong Shao | $22 | $18.73 | +113.8% | Aug 23, 2022 |
| Nomura | Martin Heung | $36.3 | $31.74 | +252.8% | Jul 1, 2022 |
| Citigroup | Analyst unavailable | $51.59 | $28.17 | +401.4% | Jun 21, 2022 |
| J.P. Morgan | Analyst unavailable | $35 | $20.8 | +240.1% | May 24, 2022 |
| Barclays | Analyst unavailable | $30 | $20.59 | +191.5% | May 24, 2022 |
| US Tiger Securities | Bo Pei | $40 | $20.76 | +288.7% | May 24, 2022 |
| UBS | Paul Gong | $34 | $25.87 | +230.4% | Apr 18, 2022 |
| Bernstein | Eunice Lee | $56 | $46.24 | +444.2% | Oct 28, 2021 |
| Deutsche Bank | Edison Yu | $51 | $40.28 | +395.6% | Aug 27, 2021 |
| Credit Suisse | Bin Wang | $72 | $43.39 | +599.7% | Aug 2, 2021 |
Track every rating change on XPEV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOperating within the People's Republic of China, XPeng Inc. is an innovator in the electric vehicle (EV) sector, focusing on the creation and sale of intelligent, connected automobiles. It handles the entire process from conceptualization to market distribution. Its diverse lineup caters to various consumer needs, featuring SUV models like the G3 and G3i, the P7 performance-oriented sports sedan, and the P5, designed as a family-friendly sedan. Beyond manufacturing vehicles, XPeng supports its customers with a comprehensive ecosystem of services. These encompass sales and financial solutions (including contracts, leasing, and loan referrals), vehicle upkeep (maintenance and super charging), and a range of digital and convenience offerings such as insurance agency, ride-hailing, technical assistance, and music subscriptions. The company was established in 2015, with its headquarters located in Guangzhou, China.
Historical context
All XPEV earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.6% | +3.3% | AutoZone pairs commercial momentum with an aggressive FY2027 expansion plan |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| LULU Lululemon Athletica Inc. | FY2026 Q2 · Calendar Q3 2026 | +63.1% | -17.4% | Lululemon lowers FY2026 outlook as North America weakens |
Latest beats and misses
Who reports nextBeat on EPS
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
Get the XPEV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-06-12T09:22:40.805924+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-24T05:31:07.874311+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T05:31:07.870561+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.